Organ-Sparing Strategies in Muscle-Invasive Bladder Cancer

References

• Babjuk M, Burger M, Compérat EM, et al. European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update. Eur Urol. 2019;76(5):639–657. doi:10.1016/j.eururo.2019.08.01631443960
   PubMed Web of Science ®Google Scholar
• Chang SS, Boorjian SA, Chou R, et al. Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline. J Urol. 2016;196(4):1021–1029. doi:10.1016/j.juro.2016.06.04927317986
   PubMed Web of Science ®Google Scholar
• Yafi FA, Aprikian AG, Chin JL, et al. Contemporary outcomes of 2287 patients with bladder cancer who were treated with radical cystectomy: a Canadian multicentre experience. BJU Int. 2010;108(4):539–545. doi:10.1111/j.1464-410X.2010.09912.x21166753
   PubMed Web of Science ®Google Scholar
• Witjes JA, Bruins HM, Cathomas R, et al. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: summary of the 2020 Guidelines. Eur Urol. 2021;79(1):82–104. doi:10.1016/j.eururo.2020.03.05532360052
   PubMed Web of Science ®Google Scholar
• Chang SS, Bochner BH, Chou R, et al. Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline. J Urol. 2017;198(3):552–559. doi:10.1016/j.juro.2017.04.08628456635
   PubMed Web of Science ®Google Scholar
• Knorr JM, Ericson KJ, Zhang JJH, et al. Comparison of major complications at 30 and 90 days following radical cystectomy. Urology. 2021;148:192–197. doi:10.1016/j.urology.2020.08.03832888983
   PubMed Web of Science ®Google Scholar
• Hautmann RE, de Petriconi RC, Volkmer BG. 25 Years of Experience With 1000 Neobladders: long-Term Complications. J Urol. 2011;185(6):2207–2212. doi:10.1016/j.juro.2011.02.00621497841
   PubMed Web of Science ®Google Scholar
• Catto JWF, Downing A, Mason S, et al. Quality of life after bladder cancer: a cross-sectional survey of patient-reported outcomes. Eur Urol. 2021;79(5):621–632. doi:10.1016/j.eururo.2021.01.03233581875
   PubMed Web of Science ®Google Scholar
• Stein JP, Lieskovsky G, Cote R, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1054 patients. J Clin Oncol. 2001;19(3):666–675. doi:10.1200/JCO.2001.19.3.66611157016
   PubMed Web of Science ®Google Scholar
• Hautmann RE, Volkmer B, Egghart G, et al. Functional Outcome and Complications following Ileal Neobladder Reconstruction in Male Patients without Tumor Recurrence. More than 35 Years of Experience from a Single Center. J Urol. 2021;205(1):174–182. doi:10.1097/JU.000000000000134532856988
   PubMed Web of Science ®Google Scholar
• Quaresma M, Coleman MP, Rachet B. 40-year trends in an index of survival for all cancers combined and survival adjusted for age and sex for each cancer in England and Wales, 1971–2011: a population-based study. Lancet. 2015;385(9974):1206–1218. doi:10.1016/S0140-6736(14)61396-925479696
   PubMed Web of Science ®Google Scholar
• Cerantola Y, Valerio M, Persson B, et al. Guidelines for perioperative care after radical cystectomy for bladder cancer: Enhanced Recovery After Surgery (ERAS®) society recommendations. Clin Nutrition. 2013;32(6):879–887. doi:10.1016/j.clnu.2013.09.014
   PubMed Web of Science ®Google Scholar
• Williams SB, Cumberbatch MGK, Kamat AM, et al. Reporting Radical Cystectomy Outcomes Following Implementation of Enhanced Recovery After Surgery Protocols: a Systematic Review and Individual Patient Data Meta-analysis. Eur Urol. 2020;78(5):719–730. doi:10.1016/j.eururo.2020.06.03932624275
   PubMed Web of Science ®Google Scholar
• Soria F, Moschini M, D’andrea D, et al. Comparative Effectiveness in Perioperative Outcomes of Robotic versus Open Radical Cystectomy: results from a Multicenter Contemporary Retrospective Cohort Study. Eur Urol Focus. 2020;6(6):1233–1239. doi:10.1016/j.euf.2018.11.00230455153
   PubMedGoogle Scholar
• Sathianathen NJ, Kalapara A, Frydenberg M, et al. Robotic assisted radical cystectomy vs open radical cystectomy: systematic review and meta-analysis. J Urol. 2019;201(4):715–720. doi:10.1016/j.juro.2018.10.00630321551
   PubMed Web of Science ®Google Scholar
• Wijburg CJ, Michels CTJ, Hannink G, et al. Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy in Bladder Cancer Patients: a Multicentre Comparative Effectiveness Study. Eur Urol. 2021;79(5):609–618. doi:10.1016/j.eururo.2020.12.02333446375
   PubMed Web of Science ®Google Scholar
• Hernández V, Espinos EL, Dunn J, et al. Oncological and functional outcomes of sexual function–preserving cystectomy compared with standard radical cystectomy in men: a systematic review. Urol Oncol. 2017;35(9):539.e17–539.e29. doi:10.1016/j.urolonc.2017.04.013
   PubMed Web of Science ®Google Scholar
• Veskimäe E, Neuzillet Y, Rouanne M, et al. Systematic review of the oncological and functional outcomes of pelvic organ-preserving radical cystectomy (RC) compared with standard RC in women who undergo curative surgery and orthotopic neobladder substitution for bladder cancer. BJU Int. 2017;120(1):12–24. doi:10.1111/bju.1381928220653
   PubMed Web of Science ®Google Scholar
• Herr HW. Transurethral Resection of Muscle-Invasive Bladder Cancer: 10-Year Outcome. J Clin Oncol. 2001;19(1):89–93. doi:10.1200/JCO.2001.19.1.8911134199
   PubMed Web of Science ®Google Scholar
• Solsona E, Iborra I, Collado A, Rubio-Briones J, Casanova J, Calatrava A. Feasibility of radical transurethral resection as monotherapy for selected patients with muscle invasive bladder cancer. J Urol. 2010;184(2):475–481. doi:10.1016/j.juro.2010.04.00820620402
   PubMed Web of Science ®Google Scholar
• Hafeez S, McDonald F, Lalondrelle S, et al. Clinical Outcomes of image guided adaptive hypofractionated weekly radiation therapy for bladder cancer in patients unsuitable for radical treatment. Int J Radiation Oncol Biol Phys. 2017;98(1):115–122. doi:10.1016/j.ijrobp.2017.01.239
   PubMed Web of Science ®Google Scholar
• Audenet F, Waingankar N, Ferket BS, et al. Effectiveness of transurethral resection plus systemic chemotherapy as definitive treatment for muscle invasive bladder cancer in population level data. J Urol. 2018;200(5):996–1004. doi:10.1016/j.juro.2018.06.00129879397
   PubMed Web of Science ®Google Scholar
• Knoedler JJ, Boorjian SA, Kim SP, et al. Does Partial Cystectomy Compromise Oncologic Outcomes for Patients with Bladder Cancer Compared to Radical Cystectomy? A Matched Case-Control Analysis. J Urol. 2012;188(4):1115–1119. doi:10.1016/j.juro.2012.06.02922901583
   PubMed Web of Science ®Google Scholar
• Kulkarni GS, Hermanns T, Wei Y, et al. Propensity score analysis of radical cystectomy versus bladder-sparing trimodal therapy in the setting of a multidisciplinary bladder cancer clinic. J Clin Oncol. 2017;35(20):2299–2305. doi:10.1200/JCO.2016.69.232728410011
   PubMed Web of Science ®Google Scholar
• Kaushik D, Wang H, Michalek J, et al. Chemoradiation Vs Radical Cystectomy for Muscle-invasive Bladder Cancer: a Propensity Score-weighted Comparative Analysis Using the National Cancer Database. Urology. 2019;133:164–174. doi:10.1016/j.urology.2019.05.06231401220
   PubMed Web of Science ®Google Scholar
• Fahmy O, Khairul-Asri MG, Schubert T, et al. A systematic review and meta-analysis on the oncological long-term outcomes after trimodality therapy and radical cystectomy with or without neoadjuvant chemotherapy for muscle-invasive bladder cancer. Urol Oncol. 2018;36(2):43–53. doi:10.1016/j.urolonc.2017.10.00229102254
   PubMed Web of Science ®Google Scholar